Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma
Completed · Phase 2
Conditions studied: Asthma
In brief
This Phase 2 study was to investigate the tolerability of unit dose budesonide (MAP0020) at three doses in pediatric volunteers with a diagnosis and history of mild-to-moderate stable asthma and evaluate the pharmacokinetic profile of budesonide resulting from inhalation aerosol delivery.
Key facts
- Study ID
- NCT00995904
- Run by
- Allergan
- People needed
- 25
- Starts
- 2009-09-01
- Expected to finish
- 2009-11-01
- Last updated by the study team
- 2014-01-09
Who can join
Age: 4 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
Where it is running
- West Coast Clinical Trials LLC — Cypress, California, United States
- Sylvana Research Associates — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.